✦ LIBER ✦

994 Association of 13-cis-retinoic acid (13CRA) and alpha-interferon-2A (IFN- α 2A) in moderate-severe cervical intraepithelial neoplasia

✍ Scribed by S. Toma; N. Ragni; P. Raffo; F. Boselli; C. Gustavino; A. Izzotti; S. Rugiati; F. Formelli; R. Rosso; L. De Cecco

Book ID: 116167738
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 162 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)96242-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of alpha-interferon 2a (α-IF

Combination of alpha-interferon 2a (α-IFN 2a) and 13-CIS-retinoic acid (13cRA) in recurrent, pre-treated squamous-cell carcinoma of head and neck (SCCHN)

✍ S. Toma; M. Airoldi; R. Palumbo; P. Raffo; C. Bumma 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 53 KB 👁 1 views

It is well known that survival of patients with advanced squamous-cell carcinoma of the head and neck (SCCHN) has not significantly improved despite recent advances in radiation and chemotherapy treatment. Specifically, a very low objective response rate can be obtained in patients with recurrent SC

Neoadjuvant cisplatin and interferonα-2b

Neoadjuvant cisplatin and interferonα-2b (IFNα-2b) with 13-cis retinoic acid (13-cRA) in bulky squamous cell carcinoma of the cervix stage IB and IIA

✍ W. Termrunguanglert; D. Tresukosol; T. Sittisomwong; A. Vasuratna; R. Lerkhachon 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Phase II clinical trial of 13-cis-retino

Phase II clinical trial of 13-cis-retinoic acid and interferon-α-2a in patients with advanced esophageal carcinoma

✍ Peter C. Enzinger; David H. Ilson; Leonard B. Saltz; Lisa K. Martin; David P. Ke 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## BACKGROUND. Interferon in combination with 5-fluorouracil has been shown to be active in squamous cell carcinoma (SCC) and adenocarcinoma (AC) of the esophagus. 13-cis-retinoic acid (CRA) has chemopreventive activity in SCC of the head and neck, and, in combination with interferon, has antitumo

Induction of cell cycle arrest and apopt

Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-α2a, and α-tocopherol in squamous cell carcinoma of the head and neck

✍ Xin Zhang; Zhuo (Georgia) Chen; Fadlo R. Khuri; Dong M. Shin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB

## Abstract ## Background. We have previously conducted phase II trials with a combination of 13‐__cis__‐retinoic acid (13‐cRA), interferon‐α2a (IFN‐α2a), and α‐tocopherol (α‐TF) in patients with advanced oral premalignant lesions and locally advanced head and neck cancer in the adjuvant settings

13-cis-Retinoic Acid and Interferon-α2a

13-cis-Retinoic Acid and Interferon-α2a Therapy in Locally Advanced Squamous Cell Carcinoma of the Cervix: p53 Alteration, Proliferating Cell Nuclear Antigen Expression and Angiogenesis Response*

✍ Dr. Navapun Charuruks; Narin Voravud; Wichai Termrungruanglert; Prasert Lertsang 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB

Interferon-α-2a with or without 13-cis r

Interferon-α-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma : Results of a randomized Phase II study (European Organization for Research and Treatment of Cancer Study 30951)

✍ Sophie D. Fosså; Gerald H. J. Mickisch; Pieter H. M. De Mulder; Simon Horenblas; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

## Background: In patients with metastatic renal cell carcinoma (mrcc), interferon-alpha (ifn) monotherapy leads to response rates of 5-15%, dependent on the selection of patients. in 1995, preclinical and clinical data indicated an improvement of these results if ifn was combined with 13-cis retin